Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page was published.
    Difference
    0.0%
    Check dated 2026-05-15T02:07:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The Record History gains a new entry for Revision: v3.5.3 and removes Revision: v3.5.2, indicating a page revision was posted. This reflects a site-level version update rather than changes to the trial information.
    Difference
    0.0%
    Check dated 2026-04-30T16:34:14.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the history display.
    Difference
    0.0%
    Check dated 2026-04-16T09:43:18.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3 on the study record history.
    Difference
    0.0%
    Check dated 2026-03-25T16:44:55.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page.
    Difference
    0.0%
    Check dated 2026-03-11T16:28:12.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page history now includes an addition of Revision: v3.4.2 and deletions of a government-funding notice and Revision: v3.4.1, which are UI/versioning updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T06:17:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.